Cargando…
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device
The necessity for bone marrow aspiration and the lack of highly sensitive assays to detect residual disease present challenges for effective management of multiple myeloma (MM), a plasma cell cancer. We show that a microfluidic cell capture based on CD138 antigen, which is highly expressed on plasma...
Autores principales: | Qasaimeh, Mohammad A., Wu, Yichao C., Bose, Suman, Menachery, Anoop, Talluri, Srikanth, Gonzalez, Gabriel, Fulciniti, Mariateresa, Karp, Jeffrey M., Prabhala, Rao H., Karnik, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379479/ https://www.ncbi.nlm.nih.gov/pubmed/28374831 http://dx.doi.org/10.1038/srep45681 |
Ejemplares similares
-
Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics
por: Deliorman, Muhammedin, et al.
Publicado: (2022) -
AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells
por: Deliorman, Muhammedin, et al.
Publicado: (2020) -
Cell Cytometry: Review and Perspective on Biotechnological Advances
por: Vembadi, Abhishek, et al.
Publicado: (2019) -
A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T lymphocytes in T cells of Smoldering Myeloma Patients
por: Bae, Jooeun, et al.
Publicado: (2014) -
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma
por: Talluri, Srikanth, et al.
Publicado: (2021)